Transcend Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$960K Sell
2,462
-106
-4% -$44.8K 0.06% 276
2026
Q1
$1.22M Buy
2,568
+572
+29% +$288K 0.1% 203
2025
Q4
$932K Buy
1,996
+477
+31% +$221K 0.07% 241
2025
Q3
$647K Buy
1,519
+487
+47% +$189K 0.05% 328
2025
Q2
$395K Sell
1,032
-278
-21% -$100K 0.03% 381
2025
Q1
$453K Hold
1,310
0.03% 378
2024
Q4
$393K Buy
1,310
+85
+7% +$29.7K 0.03% 387
2024
Q3
$498K Sell
1,225
-1
-0.1% -$366 0.03% 393
2024
Q2
$394K Buy
1,226
+16
+1% +$5.2K 0.03% 405
2024
Q1
$404K Buy
1,210
+23
+2% +$7.03K 0.03% 361
2023
Q4
$321K Buy
1,187
+54
+5% +$13.3K 0.03% 378
2023
Q3
$279K Hold
1,133
0.03% 389
2023
Q2
$344K Buy
1,133
+11
+1% +$3.06K 0.03% 348
2023
Q1
$296K Sell
1,122
-29
-3% -$7.37K 0.03% 364
2022
Q4
$276K Sell
1,151
-35
-3% -$7.84K 0.03% 380
2022
Q3
$218K Sell
1,186
-1,100
-48% -$219K 0.02% 426
2022
Q2
$384K Buy
2,286
+31
+1% +$6.66K 0.04% 335
2022
Q1
$565K Buy
2,255
+1,002
+80% +$252K 0.05% 301
2021
Q4
$322K Buy
1,253
+98
+8% +$24K 0.03% 374
2021
Q3
$279K Hold
1,155
0.03% 392
2021
Q2
$238K Hold
1,155
0.03% 289
2021
Q1
$217K Buy
+1,155
New +$204K 0.03% 368
2020
Q4
Sell
-6,640
Closed -$828K 383
2020
Q3
$828K Buy
+6,640
New +$822K 0.15% 135
2020
Q2
Sell
-8,009
Closed -$720K 149
2020
Q1
$720K Buy
+8,009
New +$1.04M 0.22% 114

Other funds holding HCA

Transcend Capital Advisors's HCA Position: Q2 2026 in Review

Transcend Capital Advisors reduced its HCA Healthcare (HCA) stake by 4.1% in Q2 2026, selling an estimated $44.8K and leaving 2,462 shares worth $960K. The position accounts for 0.06% of the portfolio, ranked #276.

Transcend Capital Advisors first reported a position in HCA in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.22M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Transcend Capital Advisors held 2,462 shares of HCA Healthcare worth $960K as of Q2 2026.
  • Transcend Capital Advisors sold 106 HCA Healthcare shares in Q2 2026, an estimated $44.8K.
  • HCA Healthcare made up 0.06% of Transcend Capital Advisors's portfolio in Q2 2026, its #276 holding.
  • Transcend Capital Advisors first reported a position in HCA Healthcare in Q1 2020 and has held it in 24 quarters since.
  • Transcend Capital Advisors's HCA Healthcare position peaked at $1.22M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.